Understanding MAT Access in the Context of Unused MAT Capacity in the United States: When Increasing Rural MAT Capacity Is Not Enough
Link
Description
Examines the factors related to buprenorphine prescriptions
to treat opioid use disorder (OUD) and the impacts of the
federal DATA waiver to increase provider capacity. Utilizes
multiple data sources to describe medication-assisted
treatment (MAT) capacity, access, barriers, availability of
MAT, and service area need in rural areas.
Author(s)
Carolyn Carpenedo Mun, Rachel Zambrano, Eileen Tallman, et al.
Citation
Substance Abuse Treatment, Prevention, and Policy, 19, 47
Date
12/2024
Tagged as
Access
· Illicit drug use
· Legislation and regulations
· Pharmacy and prescription drugs
· Prescription drug misuse
· Specialty care
· Statistics and data